HCC Neuro-Oncology Grand Rounds

Advancing Early Phase Therapies for Pediatric and AYA Brain Tumors Globally  

Sabine Mueller, MD, PhD, UCSF Pediatric Neuro-Oncology

For questions, email neuro_oncology@dfci.harvard.edu

Target Audience: Neurologists, neuro-oncologists, neurosurgeons, medical oncologists, radiation oncologists, neuropathologists, laboratory and clinical researchers, advanced providers, nurses, and technicians in various disciplines.

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.